These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14313505)

  • 1. INFECTION AND IMMUNIZATION IN MULTIPLE SCLEROSIS.
    SIBLEY WA; FOLEY JM
    Ann N Y Acad Sci; 1965 Mar; 122():457-66. PubMed ID: 14313505
    [No Abstract]   [Full Text] [Related]  

  • 2. MEASLES ANTIBODY IN PATIENTS WITH MULTIPLE SCLEROSIS.
    REED D; SEVER J; KURTZKE J; KURLAND L
    Arch Neurol; 1964 Apr; 10():402-10. PubMed ID: 14113464
    [No Abstract]   [Full Text] [Related]  

  • 3. INFECTIVE AGENTS AND MULTIPLE SCLEROSIS.
    ROSS CA; LENMAN JA; RUTTER C
    Br Med J; 1965 Jan; 1(5429):226-9. PubMed ID: 14228156
    [No Abstract]   [Full Text] [Related]  

  • 4. IMMUNIZATION.
    EDSALL G
    Mod Trends Immunol; 1963; 1():161-84. PubMed ID: 14140240
    [No Abstract]   [Full Text] [Related]  

  • 5. [What is the present status of the common virus vaccines?].
    Regnard J
    Nouv Presse Med; 1972 Jan; 1(1):33-8. PubMed ID: 5061188
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M; Berger R; Just V
    Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinology and selected virus diseases.
    Dull HB
    Adv Intern Med; 1971; 17():143-70. PubMed ID: 4950244
    [No Abstract]   [Full Text] [Related]  

  • 8. [Viral profile of multiple sclerosis. Study of virus complement fixing antibodies].
    Daniel P
    Nouv Presse Med; 1972 Jul; 1(29):1939-42. PubMed ID: 4340874
    [No Abstract]   [Full Text] [Related]  

  • 9. Herpesvirus hominis antibody in multiple sclerosis and amyotrophic lateral sclerosis.
    Catalano LW
    Neurology; 1972 May; 22(5):473-8. PubMed ID: 4343501
    [No Abstract]   [Full Text] [Related]  

  • 10. Jeryl Lynn strain live mumps virus vaccine. Durable immunity for three years following vaccination.
    Weibel RE; Buynak EB; Whitman JE; Leagus MB; Stokes J; Hilleman MR
    JAMA; 1969 Mar; 207(9):1667-70. PubMed ID: 5818350
    [No Abstract]   [Full Text] [Related]  

  • 11. [THE PROBLEM OF SPECIFIC PROPHYLAXIS AGAINST THE MAJOR VIRAL DISEASES].
    BAROIAN OB
    Vestn Akad Med Nauk SSSR; 1963; 18():36-45. PubMed ID: 14067306
    [No Abstract]   [Full Text] [Related]  

  • 12. [Virology and vaccines].
    Netter
    Rev Fr Odontostomatol; 1968 Apr; 15(4):483-92. PubMed ID: 5243711
    [No Abstract]   [Full Text] [Related]  

  • 13. [Present issues in antiviral vaccines (author's tranls)].
    Pauluzzi S
    Ann Sclavo; 1979; 21(6):823-35. PubMed ID: 554552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination measles, mumps, rubella and varicella vaccine in healthy children.
    Arbeter AM; Baker L; Starr SE; Plotkin SA
    Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits, risks and costs of viral vaccines.
    Koplan JP; Axnick NW
    Prog Med Virol; 1982; 28():180-91. PubMed ID: 6806868
    [No Abstract]   [Full Text] [Related]  

  • 16. PEDIATRIC IMMUNIZATIONS.
    MCALLISTER RM
    World Wide Abstr Gen Med; 1964 Sep; 7():8-17. PubMed ID: 14200187
    [No Abstract]   [Full Text] [Related]  

  • 17. Symposium on pertussis immunization, in honor of Dr. Pearl L. Kendrick in her eightieth year: current status of combined vaccines.
    Brown GC
    Health Lab Sci; 1971 Oct; 8(4):210-4. PubMed ID: 4940069
    [No Abstract]   [Full Text] [Related]  

  • 18. [Developments in the field of antiviral vaccinations].
    Vivell O
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):375-9. PubMed ID: 4399827
    [No Abstract]   [Full Text] [Related]  

  • 19. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH; Saracen CL; Peter G
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.